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Introduction. The association of prenatal growth with nutritional status, metabolic syndrome (MS), and insulin resistance (IR)
was studied in school-age children. Methods. A retrospective cohort study was designed linking present data of children with
perinatal records. 3325 subjects were enrolled. Anthropometry, blood pressure (BP), and pubertal status were assessed. Blood lipids,
glucose, and insulin were measured. Linear associations were assessed using the Cochran-Armitage test. Odds ratios and nonlinear
associations were computed. Results. 3290 children (52% females, mean age of 11.4 ± 1 years) were analyzed. Prevalence of obesity,
stunting, MS, and IR was 16.0%, 3.6%, 7.3%, and 25.5%, respectively. The strongest positive association was between birth weight
(BW) and obesity (OR 2.97 (95% CI 2.01–4.40) at BW ≥ 4,000 g compared to BW 2,500–2,999). The strongest inverse association
was between birth length (BL) and stunting (OR 8.70 (95% CI 3.66–20.67) at BL < 48 cm compared to BL 52-53 cm). A U-shaped
association between BL and BP ≥ 90th percentile was observed. Significant ORs were also found for MS and IR. Adjustments for
present fat mass increased or maintained the most prenatal growth influences. Conclusions. Prenatal growth influences MS, IR, and
nutritional status. Prenatal growth was more important than present body composition in determining these outcomes.
1. Introduction
Nutritional conditions during pregnancy, infancy, and child-
hood have been proposed to have a major impact on the
development of obesity and related metabolic traits such as
metabolic syndrome (MS) and insulin resistance (IR) [1–4].
Birth weight (BW), placental weight, andmeasures of size
at birth have all been related to risk factors for chronic disease
in adult life [2, 5]. Birth length (BL) has consistently been
associated with adolescent and adult height [6–8]. Shorter
than average adults are at a higher risk for obesity and are also
more susceptible to diabetes and CVD, independent of BMI;
in contrast, taller children have a higher risk for obesity [2, 9].
Obesity in childhood has consistently been related in young
adults to blood pressure (BP), insulin resistance (IR), and
lower high-density lipoprotein-cholesterol (HDL-C) concen-
tration; cardiovascular risk profile may be especially unfavor-
able in childrenwith increasedwaist circumference (WC) [2].
A recent report based upon the same sample of children as
the present study has confirmed strong associations between
obesity and BP, IR, HDL, WC, triglycerides (TG), and the
MS [10]. Gestational age (GA) is an important factor and
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premature births have been associated with increased BP and
IR [11]; the incidence of prematurity is increasing worldwide
[12].
The MS is a set of risk factors that may appear during
childhood and have been closely linked to IR [13]. Obesity,
especially of the abdominal type, and a sedentary lifestyle are
important contributors to the development of IR.
We recently studied 2,152 Chilean schoolchildren aged
10–15 years, assessing possible associations between MS and
IR to prenatal growth; however, nutritional status indicators
were not included in those analyses [14]. The main results of
that study showed that nonoptimal prenatal growth seemed
to predispose to IR, high WC, and elevated BP in children.
This study aimed to investigate the associations of prena-
tal growthwithMS and IR, including indicators of nutritional
status, using a larger sample size than the previously reported.
2. Material and Methods
2.1. Design. A retrospective cohort study of school-aged chil-
dren, from 20 public schools managed by the Municipality
of Puente Alto, Santiago, Chile, was designed. The public
schools reach nearly 40% of all primary schools in Chile [15].
All children attending 5th and 6th grade of primary education
were asked to participate in the study during the years 2009–
2011. The national individual identification number was used
to link information gathered at school with perinatal data
collected by the civil registry and subsequently published by
the National Institute of Statistics [16].
2.2. Perinatal Variables. In addition to sex, perinatal data
used in this study were birth weight (BW), birth length (BL),
and GA. They were determined at the maternity hospitals
immediately after delivery by trained personnel [17, 18].
Infants were weighed using a 1583 Tanita electronic scale
(Tanita Corporation, ArlingtonHeights, IL) with an accuracy
of 10 g or an electronic scale, Seca 345, the accuracy being
20 g (Secacorp, Hamburg, Germany). Crown-heel length was
measured using an infantometer, to the nearest 1mm. GA
was estimated as completed weeks of gestation using the date
of the last menstrual period; when this data was inaccurate
an early obstetric ultrasound was used. This ultrasound
examination is available for most women before 20 weeks of
pregnancy in Chile and most of these scans are performed
with a Voluson 730 ultrasound system (GE Healthcare,
Chalfont St. Giles, UK) or a Acuson 120XP (Acuson Inc.,
Mountain View, CA) [17]. When ultrasound examinations
were not available before 20 weeks of pregnancy, GA was
usually estimated by a postnatal clinical examination of the
newborns performed by the physician in charge. Preterm
delivery was defined as GA ≤ 37 weeks [19].
2.3.Metabolic Syndrome. Thecriteria of Cook et al. were used
to define MS in the children, when at least three out of five of
its components were present, as defined by the following cut-
off points [20]: WC ≥ 90th percentile [21], BP, either systolic
(SBP) or diastolic (DBP)≥ 90th percentile [22], lowHDL-C≤
40mg/dL, TG ≥ 110mg/dL, and glucose (GLU) ≥ 100mg/dL.
Recently proposed local cut-off points of homeostasis model
assessment index (HOMA), according to sex and pubertal
maturation, were used to classify IR [23].
2.4. Anthropometry. The evaluations at each school were
performed by a trained nurse and a nutritionist. Height and
weight were measured using a stadiometer and a beam-scale
Seca, with an accuracy of 50 g, while being barefoot and
lightly clothed. The final height and weight were the respec-
tive averages of three measurements. We calculated body
mass index (BMI = weight in kg/height2 in m) expressed in
percentiles and z-scores [24]. Nutritional status was classified
according to BMI percentiles as normal: 5 to 84, overweight:
85 to 94, obese: ≥95, and underweight: <5; short stature, or
stunting, was defined as stature-for-age <5th percentile [24].
WC was measured with an inextensible tape on the upper
lateral border of the right ilium in the midaxillary line at the
end of an exhalation [25]; two measurements were averaged
and we used the ≥90th percentile as cut-off value [21]. The
triceps and subscapular skin folds were measured with a
Harpenden caliper using a standard technique [25]; both
were used to calculate the percentage of fatmass (%FM) using
Slaughter equations [26], previously validated in Chilean
children [27, 28]. ACritikonDinamap Pro 100 blood pressure
monitor was used according to international norms and
the averages of three measurements of SBP and DBP were
obtained and classified as abnormal using the ≥90 percentile
of the same reference [22]. A voluntary private self-report of
pubertal status was requested by observation of standardized
photos of breast development in girls and genitalia in boys,
including the presence of pubic hair [29].
2.5. Blood Samples. Subjects were instructed to fast (water
was allowed) for 12 hours prior to drawing of blood; non-
compliers were asked to return another day for the blood
sampling. A single laboratory at our university was used for
all blood analyses. This laboratory has been credited by the
standard ISO 15189 for medical laboratories [30].
Venous blood samples were collected for determination
of glucose (Gluco-quant method, glucose/hexokinase, Roche
Diagnostics GmbH, Mannheim, Germany) and insulin
(immunoassay direct luminometer chemotherapy, ADVIA
Centaur XP. Bayer HealthCare LLC, Kyowa Medex Co.,
Japan); this method measures concentrations of insulin from
0.5 to 300mUI/mL (sensitivity of 0.5mUI/mL) with a coef-
ficient of variation of 3.48% and 6.17% for concentrations of
23.51mUI/mL and 62.49mUI/mL, respectively. The formula
developed by Matthews et al. [31] was used to calculate
HOMA = (glucose [mmol/liter] × insulin [mUI/mL]/22.5)
and to estimate IR [23]. TG and HDL-C were analyzed on
the Modular Analytics P-800 platform (Roche Diagnostics
GmbH, Mannheim, Germany).
2.6. Socioeconomic Status. Socioeconomic status was esti-
mated using as a proxy the number of maternal years of
formal education as collected at birth by the civil registry
[16]. This indicator has been considered closely related to the
actual socioeconomic status and the access to health services
in many studies [15, 32, 33]. Maternal level of education
was classified in the following way: (a) basic: 0–8 years of
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Table 1: Anthropometric and perinatal characteristics (mean ± SD) by sex in 3290 children from Puente Alto, Chile, 2009–2011.
Variable Total Girls Boys P value
(n = 3290) (n = 1711) (n = 1579)
Age (years) 11.4 ± 1.0 11.4 ± 1.0 11.5 ± 1.0 <0.001
Weight (kg) 43.9 ± 11.2 44.4 ± 11.1 43.4 ± 11.3 0.018
Height (cm) 146.5 ± 8.1 146.8 ± 7.7 146.2 ± 8.5 0.042
BMI (kg/m2) 20.3 ± 3.9 20.4 ± 3.9 20.1 ± 3.9 0.038
z-BMI 0.59 ± 1.1 0.59 ± 1.0 0.58 ± 1.1 ns
%FM 25.0 ± 11.4 27.0 ± 12.2 22.8 ± 10.1 <0.001
BW (g) 3350 ± 524 3292 ± 512 3412 ± 529 <0.001
BL (cm) 49.6 ± 2.4 49.2 ± 2.3 49.98 ± 2.4 <0.001
GA (w) 38.9 ± 1.8 38.9 ± 1.9 38.8 ± 1.7 ns
BMI, body mass index; %FM, percentage of fat mass; BW, birth weight; BL, birth length; GA, gestational age; ns, nonsignificant; SD, standard deviation.
education; (b) medium: 9–12 years of education; and (c)
upper: 13 and more years of education.
2.7. Statistical Analysis. The prevalence of MS and its com-
ponents were described as number of cases and percentage,
while perinatal variables used mean and standard deviation
(SD). To assess differences by sex, Pearson’s chi-square test
for proportions and independent samples Student’s t-test for
averages were used. Prevalence of MS and its components
was computed at each category of the perinatal variables.The
presences of linear trends in this prevalence were assessed
using the Cochran-Armitage test, while nonlinear associa-
tions were evaluated allowing quadratic terms in a logistic
regression.Multivariate analysis was performed using logistic
regression allowing specific adjustments for sex, Tanner
stage, and %FM; those factors could be confounders which
potentially influence the dependent variables [13, 15, 23, 34].
Crude and adjusted odds ratios (ORs) were computed, with
their 95% confidence intervals (95% CI).
All data analyses were performed using 2-sided P values
and values ≤ 0.05 were considered statistically significant.
SAS software version 9.1 was used to compute statistical
analysis.
2.8. Ethics. Parents or their representatives signed an in-
formed consent form and boys/girls an informed acceptance
form. The study was approved by the Ethics Committees of
the School of Medicine (Pontificia Universidad Cato´lica de
Chile) and the National Fund for Science and Technology
(FONDECYT).
3. Results
Initially 5,614 subjects were eligible for the study, 2,616
females and 2,998 males. A total of 3,325 children and
adolescents who presented the signed informed consent
forms were evaluated and 2289 refused to participate; from
the latter 34.5% were females and 47.4% males (𝑃 < 0.001).
Complete information on studied perinatal variables was
obtained for 3290 children (98.9%), of whom 52% were
females. There were no significant differences between those
who participated or those who did not in terms of age, years
of maternal education, BW, and BL.
Based on maternal education attainment, the socioe-
conomic status distribution in the total group of eligible
subjects was medium 60.1%, basic 33.0%, and superior 6.9%.
Proportions in the actually studied subjects were similar:
60.9%, 32.5%, and 6.6%, respectively. There were no major
associations observed with the study outcomes except for
short stature which was slightly more frequent for basic
education than the other categories of maternal education
(𝑃 = 0.039) (data not presented).
In the studied sample, mean age was 11.4± 1 years (range
10–15 years) being higher in males than in females. Most
anthropometric characteristics assessed were slightly higher
among females; only BMI (z-score) did not differ by sex.
Among boys, mean BW and BL were higher than in females
(Table 1).
Prevalence of obesity, stunting, MS, and IR was 16.0%,
3.6%, 7.3%, and 25.5%, respectively (Table 2). Obesity was
more frequent in males but stunting was more frequent in
females. The prevalence of MS was higher in females; IR
did not differ between the genders. In the study cohort TG
≥ 110mg/dL was the most common component of the MS,
followed byWC ≥ 90th percentile. Interestingly, 99% of cases
having BP≥ 90th percentile came fromSBP≥ 90th percentile.
Several associations were observed between perinatal
variables and the outcome variables studied (Figure 1). Pos-
itive trends were observed between BW and obesity and
betweenBWandWC≥ 90th percentile; BLwas also positively
associated with obesity. Negative associations were observed
between BW and stunting and between BW and BP ≥ 90th
percentile. GA was negatively associated with MS, BP ≥
90th percentile, and TG ≥ 110mg/dL; two other negative
associations were almost significant: GA with IR (P for trend
of 0.0893) and GA with WC ≥ 90th percentile (P for trend of
0.0733). In addition, a U-shaped association between BL and
BP ≥ 90th percentile was observed. Another association was
found between BL and stunting (P for trend < 0.0001); this
association was not included in Figure 1.
Table 3 presents crude ORs for the associations described
above; bold numbers correspond to significant OR values.
Adjusted ORs for %FM and adjusted ORs for %FM, sex, and
Tanner stage are also presented.
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Table 2: Anthropometric and perinatal characteristics [n (%)] by sex in 3290 children from Puente Alto, Chile, 2009–2011.
Variable Total Girls Boys P value
(n = 3290) (n = 1711) (n = 1579)
Obesity (BMI ≥ 95 percentile) 527 (16.0) 227 (13.3) 300 (19.0) 0.002
Stunting (stature-for-age < 5th percentile) 120 (3.6) 63 (3.7) 57 (3.1) 0.049
MS (≥3 components) 239 (7.3) 150 (8.8) 89 (5.6) 0.001
HDL-C ≤ 40mg/dL 555 (16.9) 324 (18.9) 231 (14.6) 0.001
TG ≥ 110mg/dL 878 (26.7) 530 (31.0) 348 (22.0) <0.001
SBP (mmHg) ≥ 90th percentile 349 (10.6) 199 (11.6) 150 (9.5) ns
DBP (mmHg) ≥ 90th percentile 24 (0.73) 17 (1.0) 7 (0.4) ns
BP (mmHg) ≥ 90th percentile 354 (10.8) 201 (11.7) 153 (9.7) ns
WC (cm) ≥ 90th percentile 697 (21.2) 405 (23.7) 292 (18.5) <0.001
Glucose (mg/dL) ≥ 100mg/dL 235 (7.1) 96 (5.6) 139 (8.8) <0.001
IR (HOMA ≥ 90th percentile) 838 (25.5) 424 (25.2) 414 (26.4) ns
BMI, body mass index; MS, metabolic syndrome; HDL-C, high-density lipoprotein; TG, triglycerides; SBP, systolic blood pressure; DBP, diastolic blood
pressure; BP, blood pressure; WC, waist circumference; HOMA, homeostasis model assessment; IR, insulin resistance; ns, nonsignificant.
The lowest prevalence of obesity and WC ≥ 90th per-
centile at school-age was observed within the 2500–2999 g
BW category and was therefore considered as the reference
level. This prevalence increased with BW categories, almost
tripling the odds for obesity and almost doubling the odds
for WC ≥ 90th percentile at the highest category of BW.
Adjustments for %FM increased most ORs. Adjustment for
%FM, sex, and Tanner stage for obesity maintained similar
values. Adjustments for %FM and for %FM, sex, and Tanner
stage showed a slight increase of OR values for WC ≥ 90th
percentile in the <2500 g BW category.
BW had an inverse association with the prevalence of
stunting. Crude ORs in the 3500 g and over categories were
protective; those values did not change after adjustments for
%FM but disappeared after further adjustment for sex and
Tanner stage.
BW did not show an influence on BP ≥ 90th percentile
when assuming the 2500–2999 g BW category as reference
(Table 3). However, when selecting the BW category with the
lowest prevalence of BP ≥ 90th percentile as reference, that
is, 3500–3999 g, the lowest BW category, that is, <2500 g, pre-
sented a higher risk for BP ≥ 90th percentile: OR 1.80 (95CI:
1.12–2.90); no changes were observed after adjustments.
BW had an inverse influence on IR prevalence. Crude
ORs in the 3000 g and over categories were protective; those
values were stable after adjustments.
52-53 cm BL was the category with the lowest prevalence
of BP ≥ 90th percentile at school-age and was considered as
the reference level. Both, the lowest and highest categories of
BL doubled the risk of BP ≥ 90th percentile, depicting a U-
shaped behavior. Adjustments for %FM and for %FM, sex,
and Tanner stage maintained these ORs only for BL < 48 cm.
BL categories below 50 cm were protective for obesity.
ORs declined and were more protective when adjusting for
%FM.These associations disappeared when further adjusting
for sex and Tanner stage.
52-53 cm BL was the category with the lowest prevalence
of stunting at school-age; BL≥ 54 cm category did not present
stunted children. OR values< 50 cm showed a risk of at least 5
times the observed in the reference category. Adjustments for
%FM and for %FM, sex, and Tanner stage maintained these
ORs.
One BL category, that is, 48-49 cm, increased the risk for
HOMA-IR just when adjusting for %FM, sex, and Tanner
stage.
GA ≥ 41 weeks was the category with the lowest preva-
lence of BP ≥ 90th percentile, MS, and TG ≥ 110mg/dL at
school-age and was considered the baseline level. Both, crude
and adjusted ORs of prematurity, defined as GA ≤ 37 weeks,
behaved in a similar way showing the highest figures for BP
≥ 90th percentile, MS, and TG ≥ 110mg/dL. No associations
were found for GA and IR.
4. Discussion
This is the first study focusing upon associations between
perinatal factors and nutritional status, MS, and IR in
Chilean children. We observed that prenatal growth influ-
ences obesity characteristics,MS, IR, and stunting. In general,
prenatal growth seemed to be more important in predicting
these associations than present body composition because
adjustments for present fat mass increased or maintained the
most prenatal growth influences. Small body size at birth was
associated with elevated BP, IR, and MS, while a large body
size at birthwas associatedwithmeasurements of obesity.The
undeniable role of prenatal growth on metabolic outcomes
appears, even in school-aged children, whose metabolic
damages are only developing.
The finding of a U-shaped association between BL and
BP ≥ 90th percentile is consistent with the well-documented
associations between both low and high values of BW and BL
with many perinatal health indicators in previous reports [19,
35].
The associations of BW with a higher prevalence of
obesity or increased adiposity have been observed in previous
studies [18, 36]. In our report there was also a nonsignificant
tendency towards a J-shaped association which according to
other studies may be stronger and significant at later ages.
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Figure 1: Association of perinatal variables and outcomes at 10–15 years of age, Puente Alto, Chile, 2009–2011. Association of BWwith obesity
((a) P for trend <0.0001), stunting ((b) P for trend <0.0001), WC ≥ 90th percentile ((c) P for trend =0.0069), and BP ≥ 90th percentile ((d) P
for trend =0.0176). Associations of BL with obesity ((e) P for trend =0.0027) and BP ≥ 90th percentile ((f) 𝑃 = 0.0002 linear term, 𝑃 = 0.0029
quadratic term). Associations of GA at birth with MS ((g) P for trend =0.0083), BP ≥ 90th percentile ((h) P for trend =0.0255), and TG >
110mg/dL ((i) P for trend =0.0435). Panels (a), (c), and (e) show that, as the value of the perinatal variable increases, it also increases the
prevalence of obesity or WC ≥ 90th percentile at 10–14 years of age. (b), (d), (g), (h), and (i) behave inversely; as the value of the perinatal
variable increases, prevalence of stunting, BP ≥ 90th percentile, MS, or TG > 110mg/dL decreases. Panel (f) shows a U-shaped behavior,
denoting that the lowest and highest values of BL have the highest prevalence of BP ≥ 90th percentile, Puente Alto, Chile, 2009–2011. BW,
birth weight; BL, birth length; GA, gestational age; WC, waist circumference; BP, blood pressure; MS: metabolic syndrome; TG, triglycerides;
perc, percentile.
For example, the 1958 British birth cohort study showed
that the association between BW and BMI was positive and
weak becoming more J-shaped with increasing age; BMI
was assessed at 7, 11, 16, 23, and 33 years in that study [37].
This inverse association between low BW and obesity and
WC > 90th percentiles has been explained by Hales and
Barkerwith the “thrifty phenotype” hypothesis.This proposes
a greater susceptibility of the newborns with low BW to
develop IR in order to survive intrauterine malnutrition and
determine adaptive responses as diet preference to high-
fat, hyperphagia, decreased muscle development, and large
deposit of visceral adipose tissue [38].
BL was positively associated with obesity, probably
reflecting the well-known previously reported finding that
weight and height are positively correlated during adoles-
cence but not during adulthood [9].
GA was inversely associated with important metabolic
risk factors, BP≥ 90th percentile, TG≥ 110mg/dL,WC≥ 90th
percentile, andMS as awhole, in these children. As previously
mentionedprematuritywas defined in this study as≤37weeks
following recent national recommendations [35]. This fact
leads to estimating a higher proportion of risky premature
births at the national level; live birthswith 37weeks, estimated
to be in 6%, would add the proportion traditionally defined
as premature births with GA < 37 w, which are now reaching
6.13% for 2011 [16, 35]. The incidence of preterm is increasing
worldwide and, as previously mentioned, has been associated
with increased BP and IR [11, 12]. A lower GA necessarily
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Table 3: Trends of the main outcomes in school-age children with perinatal variables. Prevalence and crude ORs and ORs adjusted by %FM,
Puente Alto, Chile, 2009–2011.
BW (g) 𝑛 Obesity (%) OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
<2500 161 11.8 1.20 0.69–2.11 1.81 0.81–4.05 2.11 0.89–4.98
2500–2999 500 10.0 1.00 Baseline 1.00 Baseline 1.00 Baseline
3000–3499 1335 14.0 1.47 1.05–2.04 2.00 1.28–3.13 2.06 1.27–3.35
3500–3999 992 19.8 2.22 1.59–3.09 3.55 2.26–5.58 3.07 1.87–5.04
≥4000 302 24.8 2.97 2.01–4.40 3.94 2.26–6.87 2.81 1.52–5.20
BW (g) n WC ≥ 90th percentile (%) OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
<2500 161 19.9 1.18 0.75–1.85 2.64 1.29–5.39 2.65 1.29–5.45
2500–2999 500 17.4 1.00 Baseline 1.00 Baseline 1.00 Baseline
3000–3499 1335 19.7 1.17 0.89–1.52 1.53 1.03–2.29 1.49 0.99–2.23
3500–3999 992 23.5 1.46 1.11–1.92 1.94 1.29–2.93 1.79 1.18–2.72
≥4000 302 27.2 1.77 1.26–2.49 1.75 1.03–2.98 1.54 0.89–2.65
BW (g) n Stunting (%) OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
<2500 161 6.8 1.11 0.54–2.26 1.02 0.5–2.08 0.65 0.37–1.13
2500–2999 500 6.2 1.00 Baseline 1.00 Baseline 1.00 Baseline
3000–3499 1335 4.3 0.68 0.43–1.06 0.67 0.42–1.05 0.75 0.47–1.18
3500–3999 992 1.7 0.26 0.15–0.48 0.27 0.15–0.50 1.08 0.71–1.63
≥4000 302 1.3 0.20 0.07–0.58 0.22 0.08–0.63 1.29 0.54–3.12
BW (g) n BP ≥ 90th percentile (%) OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
<2500 161 15.5 1.35 0.81–2.23 1.41 0.85–2.34 1.42 0.85–2.35
2500–2999 500 12.0 1.00 Baseline 1.00 Baseline 1.00 Baseline
3000–3499 1335 10.9 0.89 0.65–1.23 0.90 0.65–1.24 0.90 0.65–1.25
3500–3999 992 9.3 0.75 0.53–1.06 0.73 0.52–1.03 0.74 0.52–1.05
≥4000 302 10.6 0.87 0.55–1.37 0.80 0.51–1.27 0.82 0.52–1.30
BW (g) n IR OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
<2500 161 24.8 0.75 0.5–1.12 0.83 0.53–1.30 0.82 0.52–1.29
2500–2999 500 30.6 1.00 Baseline 1.00 Baseline 1.00 Baseline
3000–3499 1335 24.5 0.74 0.59–0.92 0.70 0.55–0.90 0.66 0.51–0.85
3500–3999 992 25.3 0.77 0.61–0.98 0.67 0.51–0.87 0.60 0.46–0.78
≥4000 302 28.2 0.89 0.65–1.22 0.67 0.47–0.95 0.57 0.40–0.82
BL (cm) n BP ≥ 90th percentile (%) OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
<48 457 16.6 2.22 1.49–3.31 2.25 1.51–3.35 2.22 1.48–3.33
48-49 976 10.9 1.36 0.94–1.97 1.34 0.93–1.95 1.33 0.91–1.94
50-51 1264 9.3 1.15 0.80–1.65 1.12 0.78–1.62 1.12 0.77–1.61
52-53 522 8.2 1.00 Baseline 1.00 Baseline 1.00 Baseline
≥54 71 15.5 2.04 1.00–4.17 1.93 0.94–3.96 1.93 0.94–3.96
BL (cm) n Obesity (%) OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
<48 457 12.3 0.64 0.45–0.92 0.38 0.23–0.62 0.65 0.37–1.13
48-49 976 13.3 0.71 0.53–0.95 0.43 0.29–0.66 0.75 0.47–1.18
50-51 1264 18.2 1.03 0.79–1.34 0.81 0.56–1.18 1.08 0.71–1.63
52-53 522 17.8 1.00 Baseline 1.00 Baseline 1.00 Baseline
≥54 71 25.4 1.57 0.88–2.80 1.29 0.56–2.96 1.29 0.54–3.12
BL (cm) n Stunting (%) OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
<48 457 9.2 8.70 3.66–20.67 8.64 3.63–20.57 8.74 3.65–20.94
48-49 976 5.2 4.74 2.02–11.12 4.86 2.07–11.42 4.98 2.11–11.75
50-51 1264 1.2 1.45 0.58–3.62 1.51 0.6–3.76 1.52 0.61–3.79
52-53 522 1.2 1.00 Reference 1.00 Reference 1.00 Reference
≥54 71 0.0 — — —
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BL (cm) n IR OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
<48 457 25.8 1.12 0.84–1.49 1.15 0.83–1.58 1.38 0.99–1.91
48-49 976 27.4 1.21 0.95–1.55 1.19 0.91–1.56 1.40 1.06–1.84
50-51 1264 25.9 1.12 0.88–1.42 1.05 0.81–1.36 1.13 0.87–1.48
52-53 522 23.8 1.00 Baseline 1.00 Baseline 1.00 Baseline
≥54 71 28.2 1.26 0.72–2.19 1.04 0.56–1.94 1.00 0.53–1.85
GA (w) n BP ≥ 90th percentile OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
≤37 431 13.7 1.73 1.09–2.75 1.74 1.09–2.78 1.77 1.11–2.82
38 685 11.5 1.42 0.91–2.21 1.42 0.91–2.21 1.43 0.92–2.22
39 928 10.9 1.33 0.87–2.04 1.36 0.88–2.08 1.37 0.89–2.10
40 889 9.6 1.15 0.75–1.78 1.17 0.76–1.82 1.18 0.76–1.83
≥41 357 8.4 1.00 Baseline 1.00 Baseline 1.00 Baseline
GA (w) n MS (%) OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
≤37 431 10.2 2.14 1.21–3.78 2.37 1.28–4.39 2.46 1.33–4.55
38 685 8.2 1.68 0.97–2.90 1.76 0.97–3.17 1.78 0.99–3.22
39 928 6.5 1.30 0.76–2.24 1.51 0.84–2.70 1.56 0.87–2.79
40 889 6.9 1.39 0.81–2.38 1.55 0.86–2.77 1.58 0.88–2.84
≥41 357 5.0 1.00 Baseline 1.00 Baseline 1.00 Baseline
GA (w) n TG ≥ 110mg/dL (%) OR 95% CI OR∗ 95% CI OR∗∗ 95% CI
≤37 431 30.6 1.41 1.03–1.94 1.48 1.06–2.07 1.52 1.09–2.13
38 685 27.0 1.18 0.88–1.59 1.19 0.87–1.63 1.21 0.88–1.65
39 928 25.2 1.08 0.81–1.44 1.14 0.85–1.54 1.16 0.86–1.57
40 889 27.2 1.20 0.90–1.59 1.28 0.95–1.73 1.30 0.96–1.75
≥41 357 23.8 1.00 Baseline 1.00 Baseline 1.00 Baseline
∗OR adjusted by %FM.
∗∗OR adjusted by %FM, sex, and Tanner stage.
WC,waist circumference; BP, blood pressure;MS,metabolic syndrome; TG, triglycerides; BP, blood pressure; HOMA-IR: homeostasismodel assessment index-
insulin resistance; BW, birth weight; BL, birth length; GA, gestational age; OR, odds ratio; CI, confidence interval, %FM: percentage of fat mass.
implies a lower fetal growth as estimated byBWandBL;much
more attention should be given to its prevention.
National proportions of BL < 50 cm and ≥54 cm are now
reaching 44% and 2.5%, respectively, meanwhile national
proportions of BW < 3000 g and ≥4000 g are now reaching
21.8% and 9%, respectively [16, 18, 19, 35]. It can be inferred
that BL < 50 cm is the most frequent factor of risk in this
study. Anyway, there is a clear need to avoid extreme values
of perinatal variables.
Most of these results confirmed observations of a previ-
ous study [6]. However, this is the first Chilean sample that
shows U- or J-shaped nature of some of the associations [39–
46]. All previous studies had a lower sample size than the
present study and also less power to detect J- or U-shaped
associations between BL and BP. Besides, the other seven
quoted reports apparently did not search for the possible U-
shaped associations of BW with obesity or WC; anyway, in
most of them infants or children were too young to show that
kind of associations as discussed previously [37].
There are some weaknesses in our study that need to
be addressed. The sample comes from all public schools
in Puente Alto, the county with the highest number of
inhabitants in Chile reaching more than 600,000 [16]. Cases
that did not sign the informed consent were mostly boys.
However the final study sample consisted of 52% females and
48% males, with a similar sex distribution to all live births
at the national level [16]. No significant differences were
found between the students who signed and did not sign the
informed consent with respect to their prenatal andmaternal
characteristics. These findings suggest that there was not a
biased selection of study subjects due to follow-up losses.
Another limitation of this study is the lack of consensus on the
diagnostic classifications of MS in children older than 6 years
[18, 47, 48]; this difficulty is due to the possible influences of
growth and puberty [49].
Body composition at school-age would need to be asso-
ciated with the same information at birth and also during
pregnancy [50]. Moreover, othermaternal data could provide
light on the role of nutritional status and certain pathologies
on the observed results of this study. Although there is
a known association between nutrition during pregnancy,
infancy, and childhood with metabolic disorders, specific
studies in different settings are needed [1–4].
5. Conclusions
Prenatal growth is related to MS, IR, and nutritional status
in this large sample of 3290 Chilean children. Fetal growth
seemed to be generally more important in these associations
than in present body composition because adjustments for
8 BioMed Research International
present fat mass increased or maintained the most prenatal
growth influences.
The most significant results may include association
of anthropometry at birth with MS, obesity, BP ≥ 90th
percentile, and stunting. Other results confirmed previous
observations regarding high risk of obesity and high risk of
WC ≥ 90th percentile in newborns who weighed ≥ 4000 g at
delivery. BWhad a strong negative associationwith BP≥ 90th
percentile as previously reported. Interestingly, BL < 50 cm
was associated with at least ∼30% reduction in the risk of
obesity and at least five times increase in the OR of stunting.
The lowest and highest categories of BL were associated with
a 2-fold increase in the risk of high BP. On the other hand,
children who were born ≤37 weeks exhibited higher risk for
BP ≥ 90th percentile, hypertriglyceridemia, and MS.
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